Home

Prashant Patel

CIK 1617460 · Chief Executive Officer · last filed 2026-06-25

Prashant Patel is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing shows the insider exercised options on $500 of WGRX on Jun 25, 2026. Across all open-market trades the lifetime net is −$113.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.59M

Companies

2

Total Filings

12

Lifetime Open-Market Net

-$113.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WGRX Chief Executive Officer 296,365 $3.52 $1.04M $0 4 2026-06-25
MEDS Interim CFO and Director 153,164 $3.55 $543.7K -$113.5K 7 2024-05-28

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-25 WGRX Exer (X) +100,000 $500 EDGAR
2026-06-25 WGRX Grant (A) +5,000,000 $1.00M EDGAR
2026-04-23 WGRX Grant (A) +5,000,000 $1.00M EDGAR
2025-03-25 WGRX Grant (A) +4,082,247 $0 EDGAR
2024-05-28 MEDS Grant (A) +10,000 $0 EDGAR
2024-01-16 MEDS Grant (A) +150,000 $0 EDGAR
2022-09-16 MEDS Grant (A) +8,620 $0 EDGAR
2021-04-20 MEDS Sell (S) −7,500 -$32.9K EDGAR
2020-12-16 MEDS Sell (S) −7,500 -$39.7K EDGAR
2020-07-21 MEDS Sell (S) −7,500 -$40.9K EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.